Bayesian Capital Management, LP Viatris Inc Transaction History

Bayesian Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $558,078 - $690,439	63,635 New	63,635 $689,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $700,854 - $799,532	77,700 New	77,700 $775,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $929,552 - $1.23 Million	106,600 Added 705.96%	121,700 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $1.18 Million - $1.55 Million	-139,300 Reduced 90.22%	15,100 $129,000
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $1.54 Million - $1.89 Million	154,400 New	154,400 $1.62 Million
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $1.08 Million - $1.7 Million	-110,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $1.06 Million - $1.29 Million	87,600 Added 387.61%	110,200 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $299,450 - $341,938	22,600 New	22,600 $306,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $629,045 - $783,274	-48,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $334,612 - $456,491	24,622 Added 103.12%	48,500 $678,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $341,455 - $447,473	23,878 New	23,878 $447,000

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.